Cytokinetics Stock Technical Analysis
| CYTK Stock | USD 62.27 1.55 2.55% |
As of the 4th of March, Cytokinetics shows the Standard Deviation of 2.75, mean deviation of 2.18, and Risk Adjusted Performance of (0.02). Cytokinetics technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.
Cytokinetics Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Cytokinetics, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to CytokineticsCytokinetics | Build AI portfolio with Cytokinetics Stock |
Cytokinetics Analyst Consensus
| Target Price | Consensus | # of Analysts | |
| 91.17 | Strong Buy | 21 | Odds |
Most Cytokinetics analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Cytokinetics stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Cytokinetics, talking to its executives and customers, or listening to Cytokinetics conference calls.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cytokinetics. Projected growth potential of Cytokinetics fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Cytokinetics assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share (6.54) | Revenue Per Share | Quarterly Revenue Growth 0.049 | Return On Assets | Return On Equity |
The market value of Cytokinetics is measured differently than its book value, which is the value of Cytokinetics that is recorded on the company's balance sheet. Investors also form their own opinion of Cytokinetics' value that differs from its market value or its book value, called intrinsic value, which is Cytokinetics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cytokinetics' market value can be influenced by many factors that don't directly affect Cytokinetics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Cytokinetics' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Cytokinetics should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Cytokinetics' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Cytokinetics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Cytokinetics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Cytokinetics.
| 12/04/2025 |
| 03/04/2026 |
If you would invest 0.00 in Cytokinetics on December 4, 2025 and sell it all today you would earn a total of 0.00 from holding Cytokinetics or generate 0.0% return on investment in Cytokinetics over 90 days. Cytokinetics is related to or competes with Nuvalent, Abivax SA, Axsome Therapeutics, Rhythm Pharmaceuticals, Halozyme Therapeutics, Jazz Pharmaceuticals, and Corcept Therapeutics. Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializ... More
Cytokinetics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Cytokinetics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Cytokinetics upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.05) | |||
| Maximum Drawdown | 15.74 | |||
| Value At Risk | (3.85) | |||
| Potential Upside | 3.98 |
Cytokinetics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Cytokinetics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Cytokinetics' standard deviation. In reality, there are many statistical measures that can use Cytokinetics historical prices to predict the future Cytokinetics' volatility.| Risk Adjusted Performance | (0.02) | |||
| Jensen Alpha | (0.13) | |||
| Total Risk Alpha | (0.23) | |||
| Treynor Ratio | (0.17) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Cytokinetics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Cytokinetics March 4, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.02) | |||
| Market Risk Adjusted Performance | (0.16) | |||
| Mean Deviation | 2.18 | |||
| Coefficient Of Variation | (2,775) | |||
| Standard Deviation | 2.75 | |||
| Variance | 7.54 | |||
| Information Ratio | (0.05) | |||
| Jensen Alpha | (0.13) | |||
| Total Risk Alpha | (0.23) | |||
| Treynor Ratio | (0.17) | |||
| Maximum Drawdown | 15.74 | |||
| Value At Risk | (3.85) | |||
| Potential Upside | 3.98 | |||
| Skewness | (0.61) | |||
| Kurtosis | 1.57 |
Cytokinetics Backtested Returns
Cytokinetics secures Sharpe Ratio (or Efficiency) of -0.0303, which signifies that the company had a -0.0303 % return per unit of risk over the last 3 months. Cytokinetics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Cytokinetics' Mean Deviation of 2.18, standard deviation of 2.75, and Risk Adjusted Performance of (0.02) to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.64, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Cytokinetics' returns are expected to increase less than the market. However, during the bear market, the loss of holding Cytokinetics is expected to be smaller as well. At this point, Cytokinetics has a negative expected return of -0.083%. Please make sure to confirm Cytokinetics' treynor ratio, kurtosis, as well as the relationship between the Kurtosis and day typical price , to decide if Cytokinetics performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.18 |
Insignificant reverse predictability
Cytokinetics has insignificant reverse predictability. Overlapping area represents the amount of predictability between Cytokinetics time series from 4th of December 2025 to 18th of January 2026 and 18th of January 2026 to 4th of March 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Cytokinetics price movement. The serial correlation of -0.18 indicates that over 18.0% of current Cytokinetics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.18 | |
| Spearman Rank Test | -0.03 | |
| Residual Average | 0.0 | |
| Price Variance | 5.25 |
Cytokinetics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Cytokinetics Technical Analysis
The output start index for this execution was two with a total number of output elements of fifty-nine. The Normalized Average True Range is used to analyze tradable apportunities for Cytokinetics across different markets.
About Cytokinetics Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Cytokinetics on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Cytokinetics based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Cytokinetics price pattern first instead of the macroeconomic environment surrounding Cytokinetics. By analyzing Cytokinetics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Cytokinetics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Cytokinetics specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2023 | 2024 | 2025 | 2026 (projected) | Interest Debt Per Share | 8.43 | 7.82 | 10.7 | 7.33 | Revenue Per Share | 0.078 | 0.16 | 0.73 | 0.7 |
Cytokinetics March 4, 2026 Technical Indicators
Most technical analysis of Cytokinetics help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Cytokinetics from various momentum indicators to cycle indicators. When you analyze Cytokinetics charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.02) | |||
| Market Risk Adjusted Performance | (0.16) | |||
| Mean Deviation | 2.18 | |||
| Coefficient Of Variation | (2,775) | |||
| Standard Deviation | 2.75 | |||
| Variance | 7.54 | |||
| Information Ratio | (0.05) | |||
| Jensen Alpha | (0.13) | |||
| Total Risk Alpha | (0.23) | |||
| Treynor Ratio | (0.17) | |||
| Maximum Drawdown | 15.74 | |||
| Value At Risk | (3.85) | |||
| Potential Upside | 3.98 | |||
| Skewness | (0.61) | |||
| Kurtosis | 1.57 |
Cytokinetics March 4, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Cytokinetics stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 83,327 | ||
| Daily Balance Of Power | 0.61 | ||
| Rate Of Daily Change | 1.03 | ||
| Day Median Price | 61.29 | ||
| Day Typical Price | 61.62 | ||
| Price Action Indicator | 1.76 |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cytokinetics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. For more information on how to buy Cytokinetics Stock please use our How to buy in Cytokinetics Stock guide.You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cytokinetics. Projected growth potential of Cytokinetics fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Cytokinetics assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share (6.54) | Revenue Per Share | Quarterly Revenue Growth 0.049 | Return On Assets | Return On Equity |
The market value of Cytokinetics is measured differently than its book value, which is the value of Cytokinetics that is recorded on the company's balance sheet. Investors also form their own opinion of Cytokinetics' value that differs from its market value or its book value, called intrinsic value, which is Cytokinetics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cytokinetics' market value can be influenced by many factors that don't directly affect Cytokinetics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Cytokinetics' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Cytokinetics should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Cytokinetics' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.